Termination of the term for submission of applications for mandatory conversion

MD Medical Group IPJSC (“MD Medical”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, hereby informs that the deadline for submission of applications for mandatory conversion of  Global Depositary Receipts (GDRs) of MD MEDICAL GROUP INVESTMENTS PLC (ISIN US55279C2008), representing rights to shares of IPJSC “MD Medical Group” where such rights are recorded by foreign organisations, expired on September 25, 2025.

The period for submission of applications for mandatory conversion was 120 calendar days, from May 28, 2025 to September 25, 2025. The procedure and deadlines for mandatory conversion are regulated by Article 5 of Federal Law dated August 04, 2023 No. 452-FZ (publication.pravo.gov.ru/document/0001202308040059?index=54) and the decision of the Board of Directors of the Bank of Russia dated April 12, 2024 (www.cbr.ru/rbr/dir_decisions/rsd_2024-04-12_34_05).

According to the information available to the Company, not all GDR holders were able to submit an application for mandatory conversion to the depository holding the depo account for the depositary programme used to record rights to the international company's shares - JSC “Rakurs Invest”. The Company also supposes that probably not all submitted applications could be satisfied by JSC “Rakurs Invest” due to current legislative restrictions.

According to the information available to the Company, as of the date of publication of this press release there is no regulatory framework in the Russian Federation that would determine possible actions of holders of securities of foreign issuers certifying rights in respect of shares of joint-stock companies with the status of an international company into shares of such joint-stock companies who, for different reasons, did not participate in mandatory conversion.

GDR holders are advised to follow further changes in the legislation of the Russian Federation, as well as possible disclosures of information on the Company’s official website https://www.mcclinics.ru/.

More detailed information on the conversion procedure can also be found in a separate section on the Company's official website: https://www.mcclinics.com/investors/qa/.

Any additional questions the GDR holders may address to the Company’s IR department at ir@mcclinics.ru and “Rakurs Invest” at info@rakursinvest.ru.

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 87 state-of-the-art healthcare facilities, including 14 multidisciplinary hospitals and 73 out-patient clinics in 35 regions of the Russian Federation. In 2024, MD Medical Group's revenue amounted to RUB 33.1 bln while EBITDA stood at RUB 10.7 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).